Swiss regulator warns against dangerous weight loss products
Select your language
Generated with artificial intelligence.
Listening:
Swiss regulator warns against dangerous weight loss products
The Swiss agency for therapeutic products Swissmedic has warned against counterfeit, misleading or unauthorised weight loss products. They may contain undeclared substances that are harmful to health and may be of poor quality or incorrectly dosed.
GLP-1 receptor antagonist active substances are currently very much present on social media, Swissmedic wrote on Tuesday. Counterfeiters and dubious suppliers are increasingly marketing capsules, drops or food supplements labelled as “GLP-1”. They often bear fictitious seals of approval or logos from authorisation regulatory authorities such as Swissmedic.
+ Get the most important news from Switzerland in your inbox
Products advertised as “natural” contained pharmacologically active substances without any declaration or dosage information. Swissmedic also noticed counterfeits and unauthorised imitation products. For example, weight loss injections with fake labels or substances that are still in development are on offer. This can be life-threatening in individual cases, warned Swissmedic.
Adapted from German by DeepL/ac
We select the most relevant news for an international audience and use automatic translation tools to translate them into English. A journalist then reviews the translation for clarity and accuracy before publication.
Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team from news agencies such as Bloomberg or Keystone.
If you have any questions about how we work, write to us at english@swissinfo.ch
In compliance with the JTI standards
More: SWI swissinfo.ch certified by the Journalism Trust Initiative
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.